MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 2, 2016, Pages 360-369

  Zhang, Ye ^a   Hu, Xingqian ^b   Miao, Xiaofei ^b   Zhu, Kuiyu ^b   Cui, Songkui ^b   Meng, Qingyang ^b   Sun, Jialin ^b   Wang, Tong ^a,b  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chemoresistance; Colorectal cancer; MiR 425 5p; PDCD10

Indexed keywords

CASPASE 3; CASPASE 7; FLUOROURACIL; MICRORNA; MICRORNA 425 5P; OXALIPLATIN; PROGRAMMED CELL DEATH 10; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MIRN425 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL DEATH; COLORECTAL TUMOR; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; MOUSE; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICE; MICRORNAS; UP-REGULATION;

EID: 84955713475     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12742     Document Type: Article

References (39)

1. Marin JJ, Sanchez de Medina F, Castano B, et al. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug Metab Rev. 2012; 44: 148-72.
2. Dy GK, Hobday TJ, Nelson G, et al. Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a north central cancer treatment group review of 3811 patients, n0144. Clin Colorectal Cancer. 2009; 8: 88-93.
3. Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013; 2: 3.
4. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002; 108: 153-64.
5. Fojo T. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs. Drug Resist Updat. 2007; 10: 59-67.
6. Glasspool RM, Teodoridis JM, Brown R. Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer. 2006; 94: 1087-92.
7. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75: 843-54.
8. Zhu W, Zhu D, Lu S, et al. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol. 2012; 29: 384-91.
9. Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009; 4: 199-227.
10. Sassen S, Miska EA, Caldas C. MicroRNA: implications for cancer. Virchows Arch. 2008; 452: 1-10.
11. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010; 11: 252-63.
12. Kutanzi KR, Yurchenko OV, Beland FA, et al. MicroRNA-mediated drug resistance in breast cancer. Clin Epigenetics. 2011; 2: 171-85.
13. Ju J. Implications of miRNAs in Colorectal Cancer Chemoresistance. Int Drug Discov. 2011; 2011:pii 2063.
14. Chen GQ, Zhao ZW, Zhou HY, et al. Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin. Med Oncol. 2010; 27: 406-15.
15. Li Y, Li W, Yang Y, et al. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res. 2009; 1286: 13-8.
16. Bourguignon LY, Singleton PA, Diedrich F. Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-gamma promotes phospholipase Cgamma1 activation, Ca(2+) signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation. J Biol Chem. 2004; 279: 29654-69.
17. Kopp F, Oak PS, Wagner E, et al. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PLoS ONE. 2012; 7: e50469.
18. Ma C, Huang T, Ding YC, et al. microRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. Int J Clin Exp Pathol. 2015; 8: 6533-9.
19. Ceppi P, Mudduluru G, Kumarswamy R, et al. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010; 8: 1207-16.
20. Wang J, Li Z, Ge Q, et al. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma. J Thorac Cardiovasc Surg. 2015; 149: 1404-14 e4.
21. Zhang Z, Li Y, Fan L, et al. microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis and. Exp Ther Med. 2015; 9: 1617-22.
22. Ge YZ, Xin H, Lu TZ, et al. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma. Sci Rep. 2015; 5: 10328.
23. Fleming NH, Zhong J, da Silva IP, et al. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer. 2015; 121: 51-9.
24. Zhang H, Ma X, Deng X, et al. PDCD10 interacts with STK25 to accelerate cell apoptosis under oxidative stress. Front Biosc. 2012; 17: 2295-305.
25. Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999; 10: 663-9.
26. Dallas NA, Xia L, Fan F, et al. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 2009; 69: 1951-7.
27. Blower PE, Chung JH, Verducci JS, et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther. 2008; 7: 1-9.
28. Xia L, Zhang D, Du R, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer. 2008; 123: 372-9.
29. Song B, Wang Y, Xi Y, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 2009; 28: 4065-74.
30. Scheffer AR, Holdenrieder S, Kristiansen G, et al. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol. 2014; 32: 353-8.
31. Summerer I, Niyazi M, Unger K, et al. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol. 2013; 8: 296.
32. Hummel R, Wang T, Watson DI, et al. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol Rep. 2011; 26: 1011-7.
33. Di Leva G, Piovan C, Gasparini P, et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 2013; 9: e1003311.
34. Wang Y, Liu H, Zhang Y, et al. cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene. Sci China C Life Sci. 1999; 42: 323-9.
35. Ma X, Zhao H, Shan J, et al. PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell. 2007; 18: 1965-78.
36. Lu L, Ying K, Wei S, et al. Dermal fibroblast-associated gene induction by asiaticoside shown in vitro by DNA microarray analysis. Br J Dermatol. 2004; 151: 571-8.
37. Chen J, Tian YQ, Xiao JY. Difference expression of gene for laryngeal squamous cell carcinoma by cDNA microarray and signal pathways of cell cycle regulation and cell apoptosis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005; 30: 483-6.
38. Aguirre AJ, Brennan C, Bailey G, et al. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci USA. 2004; 101: 9067-72.
39. Huerta S, Harris DM, Jazirehi A, et al. Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int J Oncol. 2003; 22: 663-70.